Richard Strauss
Overview
Explore the profile of Richard Strauss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
2049
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esse J, Trager J, Steininger P, Bihlmaier K, Furst J, Bardonicsek-Depnering Z, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39978635
Objectives: The sensitivity of blood cultures (BCs) is limited, especially when antimicrobial therapy already has been administered or when non-culturable pathogens are causing the disease. Metagenomic next-generation sequencing of cell-free...
2.
Turner D, Rosh J, Cohen S, Griffiths A, Hyams J, Kierkus J, et al.
J Pediatr Gastroenterol Nutr
. 2024 May;
79(2):315-324.
PMID: 38801079
Objectives: To assess the efficacy, safety, immunogenicity, and pharmacokinetics through 240 weeks of ustekinumab treatment in paediatric patients from the long-term extension (LTE) of the phase 1, double-blind UniStar trial....
3.
Rosh J, Turner D, Hyams J, Dubinsky M, Griffiths A, Cohen S, et al.
J Crohns Colitis
. 2024 Feb;
18(8):1250-1260.
PMID: 38408273
Background And Aims: Most paediatric inflammatory bowel disease [IBD] studies are performed after medications are approved in adults, and the majority of participants in these studies are adolescents. We hypothesised...
4.
Erb T, Mihai S, Strauss R, Herbst L, Castellanos I, Diesch K, et al.
Antimicrob Agents Chemother
. 2023 Oct;
67(11):e0072523.
PMID: 37823695
spp. are frequently encountered in specimens from ICUs. However, most of these detections represent colonization. Nevertheless, clinical practice shows that a considerable proportion of these patients will receive antifungal therapy...
5.
Zhang N, Liu C, Steiner S, Colletti R, Baldassano R, Chen S, et al.
J Comp Eff Res
. 2023 Feb;
12(4):e220136.
PMID: 36799351
To evaluate the performance of the multiple imputation (MI) method for estimating clinical effectiveness in pediatric Crohn's disease in the ImproveCareNow registry; to address the analytical challenge of missing data....
6.
Friedrich B, Eichermuller J, Bogdan C, Cunningham S, Hackstein H, Strauss R, et al.
Pharmaceutics
. 2022 Nov;
14(11).
PMID: 36365174
Gram bacteria are very common in clinical medicine and responsible for a large number of infectious diseases. For example, Gram bacteria play a major role in causing bloodstream infections and...
7.
Freise N, Gliga S, Fischer J, Lubke N, Lutterbeck M, Scholer M, et al.
Sci Rep
. 2022 Nov;
12(1):19035.
PMID: 36351986
Establishing the optimal treatment for COVID-19 patients remains challenging. Specifically, immunocompromised and pre-diseased patients are at high risk for severe disease course and face limited therapeutic options. Convalescent plasma (CP)...
8.
Zundler S, Mardin C, Bertz S, Vitali F, Strauss R, Furst J, et al.
Pathogens
. 2022 Oct;
11(10).
PMID: 36297170
Intestinal microbiota such as play an important role in the pathogenesis of colorectal cancer. Here, we describe the case of a 47-year-old patient presenting with endophthalmitis and a liver abscess...
9.
Levy S, Heiss R, Grimm R, Grodzki D, Hadler D, Voskrebenzev A, et al.
Invest Radiol
. 2022 May;
57(11):742-751.
PMID: 35640012
Objectives: With the COVID-19 pandemic, repetitive lung examinations have become necessary to follow-up symptoms and associated alterations. Low-field MRI, benefiting from reduced susceptibility effects, is a promising alternative for lung...
10.
Valor-Mendez L, Wacker J, Schett G, Manger B, Furst J, Strauss R, et al.
Arthritis Rheumatol
. 2022 Feb;
74(7):1183.
PMID: 35137565
No abstract available.